Trends and perspectives for improving quality of chronic kidney disease care : conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Copyright © 2023 KDIGO: Kidney Disease Improving Global Outcomes. Published by Elsevier Inc. All rights reserved..
Chronic kidney disease (CKD) affects over 850 million people globally, and the need to prevent its development and progression is urgent. During the past decade, new perspectives have arisen related to the quality and precision of care for CKD, owing to the development of new tools and interventions for CKD diagnosis and management. New biomarkers, imaging methods, artificial intelligence techniques, and approaches to organizing and delivering healthcare may help clinicians recognize CKD, determine its etiology, assess the dominant mechanisms at given time points, and identify patients at high risk for progression or related events. As opportunities to apply the concepts of precision medicine for CKD identification and management continue to be developed, an ongoing discussion of the potential implications for care delivery is required. The 2022 KDIGO Controversies Conference on Improving CKD Quality of Care: Trends and Perspectives examined and discussed best practices for improving the precision of CKD diagnosis and prognosis, managing the complications of CKD, enhancing the safety of care, and maximizing patient quality of life. Existing tools and interventions currently available for the diagnosis and treatment of CKD were identified, with discussion of current barriers to their implementation and strategies for improving the quality of care delivered for CKD. Key knowledge gaps and areas for research were also identified.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:104 |
|---|---|
| Enthalten in: |
Kidney international - 104(2023), 5 vom: 01. Nov., Seite 888-903 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Eckardt, Kai-Uwe [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic kidney disease |
|---|
| Anmerkungen: |
Date Completed 23.10.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.kint.2023.05.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357477804 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357477804 | ||
| 003 | DE-627 | ||
| 005 | 20231226072657.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.kint.2023.05.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1191.xml |
| 035 | |a (DE-627)NLM357477804 | ||
| 035 | |a (NLM)37245565 | ||
| 035 | |a (PII)S0085-2538(23)00388-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Eckardt, Kai-Uwe |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Trends and perspectives for improving quality of chronic kidney disease care |b conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 KDIGO: Kidney Disease Improving Global Outcomes. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Chronic kidney disease (CKD) affects over 850 million people globally, and the need to prevent its development and progression is urgent. During the past decade, new perspectives have arisen related to the quality and precision of care for CKD, owing to the development of new tools and interventions for CKD diagnosis and management. New biomarkers, imaging methods, artificial intelligence techniques, and approaches to organizing and delivering healthcare may help clinicians recognize CKD, determine its etiology, assess the dominant mechanisms at given time points, and identify patients at high risk for progression or related events. As opportunities to apply the concepts of precision medicine for CKD identification and management continue to be developed, an ongoing discussion of the potential implications for care delivery is required. The 2022 KDIGO Controversies Conference on Improving CKD Quality of Care: Trends and Perspectives examined and discussed best practices for improving the precision of CKD diagnosis and prognosis, managing the complications of CKD, enhancing the safety of care, and maximizing patient quality of life. Existing tools and interventions currently available for the diagnosis and treatment of CKD were identified, with discussion of current barriers to their implementation and strategies for improving the quality of care delivered for CKD. Key knowledge gaps and areas for research were also identified | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a models of care | |
| 650 | 4 | |a patient-reported outcome measures | |
| 650 | 4 | |a precision medicine | |
| 700 | 1 | |a Delgado, Cynthia |e verfasserin |4 aut | |
| 700 | 1 | |a Heerspink, Hiddo J L |e verfasserin |4 aut | |
| 700 | 1 | |a Pecoits-Filho, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Ricardo, Ana C |e verfasserin |4 aut | |
| 700 | 1 | |a Stengel, Bénédicte |e verfasserin |4 aut | |
| 700 | 1 | |a Tonelli, Marcello |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Jadoul, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Winkelmayer, Wolfgang C |e verfasserin |4 aut | |
| 700 | 1 | |a Kramer, Holly |e verfasserin |4 aut | |
| 700 | 0 | |a Conference Participants |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Aly, Ziyad |e investigator |4 oth | |
| 700 | 1 | |a Ashuntantang, Gloria E |e investigator |4 oth | |
| 700 | 1 | |a Boor, Peter |e investigator |4 oth | |
| 700 | 1 | |a Calice da Silva, Viviane |e investigator |4 oth | |
| 700 | 1 | |a Coleman, Jill |e investigator |4 oth | |
| 700 | 1 | |a Coresh, Josef |e investigator |4 oth | |
| 700 | 1 | |a Delanaye, Pierre |e investigator |4 oth | |
| 700 | 1 | |a Ebert, Natalie |e investigator |4 oth | |
| 700 | 1 | |a Enghard, Philipp |e investigator |4 oth | |
| 700 | 1 | |a Feldman, Harold I |e investigator |4 oth | |
| 700 | 1 | |a Fisher, Lori |e investigator |4 oth | |
| 700 | 1 | |a Flythe, Jennifer E |e investigator |4 oth | |
| 700 | 1 | |a Fukui, Akira |e investigator |4 oth | |
| 700 | 1 | |a Grams, Morgan E |e investigator |4 oth | |
| 700 | 1 | |a Ix, Joseph H |e investigator |4 oth | |
| 700 | 1 | |a Jardine, Meg J |e investigator |4 oth | |
| 700 | 1 | |a Jha, Vivek |e investigator |4 oth | |
| 700 | 1 | |a Ju, Wenjun |e investigator |4 oth | |
| 700 | 1 | |a Jurish, Robert |e investigator |4 oth | |
| 700 | 1 | |a Kalyesubula, Robert |e investigator |4 oth | |
| 700 | 1 | |a Kashihara, Naoki |e investigator |4 oth | |
| 700 | 1 | |a Levey, Andrew S |e investigator |4 oth | |
| 700 | 1 | |a Levin, Adeera |e investigator |4 oth | |
| 700 | 1 | |a Luyckx, Valerie |e investigator |4 oth | |
| 700 | 1 | |a Małyszko, Jolanta |e investigator |4 oth | |
| 700 | 1 | |a Manski-Nankervis, Jo-Anne |e investigator |4 oth | |
| 700 | 1 | |a Navaneethan, Sankar D |e investigator |4 oth | |
| 700 | 1 | |a Obrador, Greg |e investigator |4 oth | |
| 700 | 1 | |a Ortiz, Alberto |e investigator |4 oth | |
| 700 | 1 | |a Ortiz, John |e investigator |4 oth | |
| 700 | 1 | |a Cardoso Dos Santos, Bento Fortunato |e investigator |4 oth | |
| 700 | 1 | |a Sarnak, Mark J |e investigator |4 oth | |
| 700 | 1 | |a Schaeffner, Elke |e investigator |4 oth | |
| 700 | 1 | |a Selby, Nick M |e investigator |4 oth | |
| 700 | 1 | |a Simpson, David M |e investigator |4 oth | |
| 700 | 1 | |a Solá, Laura |e investigator |4 oth | |
| 700 | 1 | |a St Peter, Wendy L |e investigator |4 oth | |
| 700 | 1 | |a Stevens, Paul E |e investigator |4 oth | |
| 700 | 1 | |a Tangri, Navdeep |e investigator |4 oth | |
| 700 | 1 | |a Tannor, Elliot Koranteng |e investigator |4 oth | |
| 700 | 1 | |a Tchokhonelidze, Irma |e investigator |4 oth | |
| 700 | 1 | |a Wilck, Nicola |e investigator |4 oth | |
| 700 | 1 | |a Wong, Michelle M Y |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international |d 1972 |g 104(2023), 5 vom: 01. Nov., Seite 888-903 |w (DE-627)NLM000007188 |x 1523-1755 |7 nnns |
| 773 | 1 | 8 | |g volume:104 |g year:2023 |g number:5 |g day:01 |g month:11 |g pages:888-903 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.kint.2023.05.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 104 |j 2023 |e 5 |b 01 |c 11 |h 888-903 | ||